Clinical trial
Activity Monitoring to Improve Patient Care During Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
NCT04878952 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Activity Monitoring to Improve Patient Care During Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
- Lead sponsor
- NRG Oncology
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- August 26, 2021
- Completion date
- August 12, 2024
- Enrollment
- 3 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer, non-small cell lung cancer stage iii, recurrent non small cell lung cancer